Announcements Trials

Browse Landscape

Phase

Status

Terminated 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Breast Neoplasms 2 Prostatic Neoplasms 1 Neuritis 1

Interventions

Docetaxel 56 Prednisone 36 enzalutamide 25 Leuprolide 24 Magnetic Resonance Spectroscopy 19 Abiraterone Acetate 19 bicalutamide 17 Radiotherapy 15 Goserelin 15 abiraterone 12 acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 11 olaparib 9 Androgen Antagonists 9 gallium 68 PSMA-11 8 cabazitaxel 8 Radiotherapy, Intensity-Modulated 8 Metformin 8 Ketoconazole 8 Gonadotropin-Releasing Hormone 8 Cyclophosphamide 8 apalutamide 7 Doxorubicin 7 luprolide acetate gel depot 6 cabozantinib 6 Radiosurgery 6 Estramustine 6 Dexamethasone 6 Calcitriol 6 Biopsy 6 pembrolizumab 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Prostatic Neoplasms × Massage × Clear all

NCT05067777 2025-12-15

mPROSTATE

University of Utah

Phase 2 Terminated

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡